Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
SeqLL logo — company profile

SeqLL

Founded 2013 United States Woburn, United States 7 employees Venture round Total: $3.00M Biotechnology, Health Care +1

General Information

Company Name SeqLL
Founded Year 2013
Location United States Woburn, United States
Employees 7
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with SeqLL. To contact SeqLL, visit seqll.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SeqLL compare?

A PDF of SeqLL and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SeqLL soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SeqLL

SeqLL Inc. is a biotechnology startup pioneering in Quantitative RNA & Specialty DNA Sequencing. Founded in 2013 in the United States, the company is at the forefront of next-generation sequencing technology with its True Single Molecule Sequencing (tSMS). SeqLL's team of top-level scientists and engineers specializes in tSMS technology, enabling the company to address gaps left by standard sequencing technologies in RNA transcriptome analysis and specialty DNA analysis. In February 2016, SeqLL secured a significant $1.00M Venture Round investment from St. Laurent Investments. The company's mission is to facilitate customer access to scientific breakthroughs through the use of tSMS technology, making science the company's passion and customer service its priority. SeqLL's innovative approach and strong investment support reflect a promising potential for catering to the research and healthcare technologies, presenting enticing opportunities for venture capital considering the growing demand and advancements in biotechnology and healthcare sectors.

Business keywords: Next-generation sequencing, RNA sequencing, DNA sequencing, Single molecule sequencing, Transcriptome analysis, Specialty DNA analysis, Scientific breakthroughs, tSMS technology, Research technology, Genomics, Research and development

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.00M 1
St. Laurent Investments
St. Laurent Investments
22 Feb 2016
Series A $1.00M 1
St. Laurent Investments
St. Laurent Investments
18 Sep 2014
Seed Round $1.00M 1
St. Laurent Investments
St. Laurent Investments
09 Jun 2014

SeqLL Alternatives & Competitors

View All Alternatives
SeqLL vs
Helicos Biosciences Corporation
Helicos Biosciences Corporation United States

The Helicos® Genetic Analysis System is the first technology capable of true direct RNA, cDNA and DN...

Series A
8 employees
Biotechnology, Health Care
SeqLL vs
Macrogen Europe
Macrogen Europe The Netherlands

Committed to Sequencing Excellence

71 employees
Biotechnology, Health Care
SeqLL vs
Sarmal, Inc.
Sarmal, Inc.

A genomics company developing next generation innovations in sequencing and advanced target sequence...

5 employees
Digital Health, Health Care
Also compare with: SeqLL vs Single Technologies Single Technologies View all alternatives

FAQ About SeqLL

Quantitative RNA & Specialty DNA Sequencing Founded in 2013, SeqLL delivers a new breed of next-generation sequencing technology to research and healthcare technologies: True Single Molecule Sequencing (tSMS). By bringing together top-level scientists and engineers with extensive expertise in tSMS...
SeqLL was founded in 2013.
SeqLL is headquartered in Woburn, United States.
SeqLL operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Next-generation sequencing, RNA sequencing, DNA sequencing and Single molecule sequencing.
SeqLL has approximately 7 employees.
SeqLL has completed 3 funding rounds, raising a total of $3.00M. The latest funding stage is Venture round.
Top alternatives and competitors to SeqLL include Helicos Biosciences Corporation, Macrogen Europe, Sarmal, Inc., Jumpcode Genomics, Single Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SeqLL and Helicos Biosciences Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SeqLL, https://www.bouncewatch.com/company/seqll-inc, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout